PURPOSE:Serum brain-derived neurotrophic factor (BDNF) is known to increase with exercise. This increase is believed to originate from the brain and it is suggested that monoamines are involved in BDNF regulation. Heat exposure could influence the supposed BDNF output from the brain. Therefore, we hypothesized that administration of a selective serotonin reuptake inhibitor could influence the exercise-induced increase in BDNF, and that peripheral BDNF will be higher when exercise is performed in the heat. METHODS:Eleven well-trained males performed 4 experimental trials on a cycle ergometer with citalopram or placebo treatment (20 mg in 12 h) in an environmental temperature of 18°C or 30°C. Blood samples (BDNF and cortisol) were taken at 4 time points: at rest, after 60 min at 55% W(max), after a time trial of 30 min at 75% W(max) and following 15 min of recovery. Heart rate and core temperature were measured. RESULTS: Performance on the time trial was 20% worse in 30°C compared to 18°C (p<0.01), without influence of citalopram. Serum BDNF was found to be lower under citalopram treatment, while basal cortisol levels were increased (p<0.05). Exercise triggered an increase in both BDNF and cortisol (p<0.001). BDNF followed the same pattern as core temperature during exercise, with higher levels of both variables in 30°C. Cortisol was also increased in 30°C compared to temperate conditions (p<0.01). CONCLUSION: Exercise caused a rise in serum BDNF and cortisol. This increase was enhanced with exercise in the heat. Since permeability of the blood-brain barrier increases with exercise in the heat, the hypothesis was raised that this causes a higher cerebral output of BDNF. Serotonergic stimulation did not increase peripheral BDNF, which was even lower with citalopram administration. Future research should focus on mechanisms behind BDNF increase with exercise.
RCT Entities:
PURPOSE: Serum brain-derived neurotrophic factor (BDNF) is known to increase with exercise. This increase is believed to originate from the brain and it is suggested that monoamines are involved in BDNF regulation. Heat exposure could influence the supposed BDNF output from the brain. Therefore, we hypothesized that administration of a selective serotonin reuptake inhibitor could influence the exercise-induced increase in BDNF, and that peripheral BDNF will be higher when exercise is performed in the heat. METHODS: Eleven well-trained males performed 4 experimental trials on a cycle ergometer with citalopram or placebo treatment (20 mg in 12 h) in an environmental temperature of 18°C or 30°C. Blood samples (BDNF and cortisol) were taken at 4 time points: at rest, after 60 min at 55% W(max), after a time trial of 30 min at 75% W(max) and following 15 min of recovery. Heart rate and core temperature were measured. RESULTS: Performance on the time trial was 20% worse in 30°C compared to 18°C (p<0.01), without influence of citalopram. Serum BDNF was found to be lower under citalopram treatment, while basal cortisol levels were increased (p<0.05). Exercise triggered an increase in both BDNF and cortisol (p<0.001). BDNF followed the same pattern as core temperature during exercise, with higher levels of both variables in 30°C. Cortisol was also increased in 30°C compared to temperate conditions (p<0.01). CONCLUSION: Exercise caused a rise in serum BDNF and cortisol. This increase was enhanced with exercise in the heat. Since permeability of the blood-brain barrier increases with exercise in the heat, the hypothesis was raised that this causes a higher cerebral output of BDNF. Serotonergic stimulation did not increase peripheral BDNF, which was even lower with citalopram administration. Future research should focus on mechanisms behind BDNF increase with exercise.
Authors: Douglas J Casa; Julie K DeMartini; Michael F Bergeron; Dave Csillan; E Randy Eichner; Rebecca M Lopez; Michael S Ferrara; Kevin C Miller; Francis O'Connor; Michael N Sawka; Susan W Yeargin Journal: J Athl Train Date: 2015-09 Impact factor: 2.860
Authors: S Alboni; R M van Dijk; S Poggini; G Milior; M Perrotta; T Drenth; N Brunello; D P Wolfer; C Limatola; I Amrein; F Cirulli; L Maggi; I Branchi Journal: Mol Psychiatry Date: 2015-09-15 Impact factor: 15.992
Authors: Igor Branchi; Sara Santarelli; Sara Capoccia; Silvia Poggini; Ivana D'Andrea; Francesca Cirulli; Enrico Alleva Journal: PLoS One Date: 2013-04-30 Impact factor: 3.240
Authors: Caren Bernardi; Ana Carolina Tramontina; Patrícia Nardin; Regina Biasibetti; Ana Paula Costa; Adriana Fernanda Vizueti; Cristiane Batassini; Lucas Silva Tortorelli; Krista Minéia Wartchow; Márcio Ferreira Dutra; Larissa Bobermin; Patrícia Sesterheim; André Quincozes-Santos; Jaqueline de Souza; Carlos Alberto Gonçalves Journal: Neural Plast Date: 2013-01-17 Impact factor: 3.599